ResearcherZhejiang UniversityActive in the last 2 years
Hongxia Xu
Matched on ORCID iD 0000-0001-5384-4627; OpenAlex author ID A5101115243, A5101880727. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2024: 3 papers · 2025: 1 paper · 2026: 2 papers
Papers 6
- SEC14L2 contributes to tumor progression by enhancing USP5-driven RBM3 deubiquitination in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41388-026-03968-6↗
- Noninvasive evaluation and clinical value prediction of tumor-infiltrating neutrophil-to-T-cell ratio in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41746-025-02303-9↗
- Lipids, lipid-lowering drug target genes and pancreatic cancer: a Mendelian randomization study. Co-author DOI 10.1007/s11096-025-01866-7↗
- Predicting Pancreatic Cancer in New-Onset Diabetes Cohort Using a Novel Model With Integrated Clinical and Genetic Indicators: A Large-Scale Prospective Cohort… Co-author DOI 10.1002/cam4.70388↗
- Sorcin can trigger pancreatic cancer-associated new-onset diabetes through the secretion of inflammatory cytokines such as serpin E1 and CCL5. Co-author DOI 10.1038/s12276-024-01346-4↗
- Author Correction: Sorcin can trigger pancreatic cancer-associated new-onset diabetes through the secretion of inflammatory cytokines such as serpin E1 and CCL… Co-author DOI 10.1038/s12276-024-01363-3↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yulian Wu · 4 shared papers, 2024–2026 · strength 0.76
- Paper Noninvasive evaluation and clinical value prediction of tumor-infiltrating neutrophil-to-T-cell ratio in pancreatic duc… DOI 10.1038/s41746-025-02303-9↗
- Paper Predicting Pancreatic Cancer in New-Onset Diabetes Cohort Using a Novel Model With Integrated Clinical and Genetic Indi… DOI 10.1002/cam4.70388↗
- Paper Sorcin can trigger pancreatic cancer-associated new-onset diabetes through the secretion of inflammatory cytokines such… DOI 10.1038/s12276-024-01346-4↗
- Yiqun Fan · 3 shared papers, 2024–2026 · strength 0.72
- Paper Lipids, lipid-lowering drug target genes and pancreatic cancer: a Mendelian randomization study. DOI 10.1007/s11096-025-01866-7↗
- Paper Noninvasive evaluation and clinical value prediction of tumor-infiltrating neutrophil-to-T-cell ratio in pancreatic duc… DOI 10.1038/s41746-025-02303-9↗
- Paper Predicting Pancreatic Cancer in New-Onset Diabetes Cohort Using a Novel Model With Integrated Clinical and Genetic Indi… DOI 10.1002/cam4.70388↗
- Zengyu Feng · 3 shared papers, 2024–2026 · strength 0.63
- Paper SEC14L2 contributes to tumor progression by enhancing USP5-driven RBM3 deubiquitination in pancreatic ductal adenocarci… DOI 10.1038/s41388-026-03968-6↗
- Paper Sorcin can trigger pancreatic cancer-associated new-onset diabetes through the secretion of inflammatory cytokines such… DOI 10.1038/s12276-024-01346-4↗
- Paper Author Correction: Sorcin can trigger pancreatic cancer-associated new-onset diabetes through the secretion of inflamma… DOI 10.1038/s12276-024-01363-3↗
- Yongji Sun · 3 shared papers, 2024 · strength 0.53
- Paper Predicting Pancreatic Cancer in New-Onset Diabetes Cohort Using a Novel Model With Integrated Clinical and Genetic Indi… DOI 10.1002/cam4.70388↗
- Paper Sorcin can trigger pancreatic cancer-associated new-onset diabetes through the secretion of inflammatory cytokines such… DOI 10.1038/s12276-024-01346-4↗
- Paper Author Correction: Sorcin can trigger pancreatic cancer-associated new-onset diabetes through the secretion of inflamma… DOI 10.1038/s12276-024-01363-3↗
- Xiawei Li · 3 shared papers, 2024 · strength 0.53
- Paper Predicting Pancreatic Cancer in New-Onset Diabetes Cohort Using a Novel Model With Integrated Clinical and Genetic Indi… DOI 10.1002/cam4.70388↗
- Paper Sorcin can trigger pancreatic cancer-associated new-onset diabetes through the secretion of inflammatory cytokines such… DOI 10.1038/s12276-024-01346-4↗
- Paper Author Correction: Sorcin can trigger pancreatic cancer-associated new-onset diabetes through the secretion of inflamma… DOI 10.1038/s12276-024-01363-3↗
- Qiaojun He · 2 shared papers, 2024 · strength 0.34
- Paper Sorcin can trigger pancreatic cancer-associated new-onset diabetes through the secretion of inflammatory cytokines such… DOI 10.1038/s12276-024-01346-4↗
- Paper Author Correction: Sorcin can trigger pancreatic cancer-associated new-onset diabetes through the secretion of inflamma… DOI 10.1038/s12276-024-01363-3↗
- Jiali Gong · 2 shared papers, 2024 · strength 0.34
- Paper Sorcin can trigger pancreatic cancer-associated new-onset diabetes through the secretion of inflammatory cytokines such… DOI 10.1038/s12276-024-01346-4↗
- Paper Author Correction: Sorcin can trigger pancreatic cancer-associated new-onset diabetes through the secretion of inflamma… DOI 10.1038/s12276-024-01363-3↗
- Yizhao Zhou · 2 shared papers, 2024 · strength 0.34
- Paper Sorcin can trigger pancreatic cancer-associated new-onset diabetes through the secretion of inflammatory cytokines such… DOI 10.1038/s12276-024-01346-4↗
- Paper Author Correction: Sorcin can trigger pancreatic cancer-associated new-onset diabetes through the secretion of inflamma… DOI 10.1038/s12276-024-01363-3↗
- Yuxuan Zhan · 1 shared paper, 2025 · strength 0.30
- Chenghong Peng · 1 shared paper, 2026 · strength 0.29
- Kai Qin · 1 shared paper, 2026 · strength 0.29
- Xiawei Li · 1 shared paper, 2026 · strength 0.24
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.